Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
1,380
Views
4
CrossRef citations to date
0
Altmetric
Articles

Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness

Veronica K. Emmericha Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USACorrespondence[email protected]
View further author information
,
Deborah Culla Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
,
Katherine A. Kellya Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information
&
Steven R. Feldmana Department of Dermatology, Center for Dermatology Research, Wake Forest School of Medicine, Winston-Salem, NC, USA;b Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA;c Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA;d Department of Dermatology, University of Southern Denmark, Odense, DenmarkView further author information
Pages 2075-2078 | Received 25 Feb 2021, Accepted 08 Apr 2021, Published online: 05 May 2021

References

  • Siegel JA, Korgavkar K, Weinstock MA. Current perspective on actinic keratosis: a review. Br J Dermatol. 2017;177(2):350–358.
  • de Oliveira ECV, da Motta VRV, Pantoja PC, et al. Actinic keratosis – review for clinical practice. Int J Dermatol. 2019;58(4):400–407.
  • Hashim PW, Chen T, Rigel D, et al. Actinic keratosis: current therapies and insights into new treatments. J Drugs Dermatol. 2019;18(5):s161–s166.
  • Blauvelt A, Kempers S, Lain E, et al. Phase 3 trials of tirbanibulin ointment for actinic keratosis. N Engl J Med. 2021;384(6):512–520.
  • Casale J, Crane JS. Fluorouracil. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK549808/
  • Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55(8):831–844.
  • Alchin DR. Ingenol mebutate: a succinct review of a succinct therapy. Dermatol Ther. 2014;4(2):157–164.
  • de Berker D, McGregor JM, Mohd Mustapa MF, et al. British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol. 2017;(1)176:20–43.
  • Yentzer B, Hick J, Williams L, et al. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol. 2009;145(2):203–205.
  • van Onzenoort HA, Menger FE, Neef C, et al. Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study. Hypertension. 2011;58(4):573–578.
  • Snyder S, Crandell I, Davis SA, et al. Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol. 2014;15(2):87–94.
  • Krejci-Manwaring J, McCarty MA, Camacho F, et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol. 2006;54(5):S235–S236.
  • Grada A, Feldman SR, Bragazzi NL, et al. Patient‐reported outcomes of topical therapies in actinic keratosis: a systematic review. Dermatol Ther. 2021;34:e14833.
  • Jorizzo J, Weiss J, Furst K, et al. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Arch Dermatol. 2004;140(7):813–816.
  • Philipp-Dormston WG, Battistella M, Boussemart L, et al. Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies. J Dermatolog Treat. 2020;31(6):576–582.
  • Neri L, Peris K, Longo C, et al. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.J Eur Acad Dermatol Venereol. 2019;33(1):93–107.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.